Delivery of heme oxygenase-1 gene using dexamethasone conjugated polyethylenimine for brain protection against ischemic stroke
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이민형 | - |
dc.date.accessioned | 2021-08-03T22:35:38Z | - |
dc.date.available | 2021-08-03T22:35:38Z | - |
dc.date.created | 2021-06-30 | - |
dc.date.issued | 2008-11-14 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/62895 | - |
dc.description.abstract | Dexamethasone is one of anti-inflammatory glucocorticoid steroids. In this research, dexamethasone was conjugated low molecular weight polyethyleneimne (2,000 Da, PEI2k). PEI has been investigated as a gene carrier for gene therapy. Therefore, dexamethasone conjugated PEI (PEI-Dexa) may have dual functions as an anti-inflammatory reagent and a gene carrier. Heme oxygenase-1 (HO-1) is an anti-apoptotic protein, which can protect cell from apoptosis under hypoxia. In this study, HO-1 gene was delivered to focal ischemic brain of stroke animal model using PEI-Dexa as a gene carrier. In divided groups of rats (n=5), empty plasmid pNull/PEI-Dexa, pNull/PEI and pSV-HO-1/PEI-Dexa complexes were injected directly into the cortex 1 hr prior to middle cerebral artery occlusion (MCAO) except control group. MCAO was performed for 50 min by 4-0 nylon filament suture into internal carotid artery via the external carotid artery in male Sprague Dawley (SD) rats (280-320g). Also, cortical blood flow was continuously monitored by Laser Doppler Flowmetry. At 24 hrs after MCAO, infarct size was evaluated by 2% 2,3,5-triphenyltetrazolium hydrochloride (TTC) staining. The level of cytokine such as TNF-α was measured in the infarcted area. The results showed that injection of pNull/PEI-Dexa reduced infarct size significantly compared with the control and pNull/PEI groups. This suggests that PEI-Dexa protects the brain cells under ischemia-reperfusion condition. The infarct size was further reduced in the group of the pSV-HO-1/PEI-Dexa group, which suggests that HO-1 has synergistic effect with PEI-Dexa in reducing inflammatory response in ischemic brain. Therefore, pSV-HO-1/PEI-Dexa complex is a potential candidate for therapeutic gene delivery to ischemic brain. | - |
dc.publisher | European Society of Gene and Cell Therapy | - |
dc.title | Delivery of heme oxygenase-1 gene using dexamethasone conjugated polyethylenimine for brain protection against ischemic stroke | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | 이민형 | - |
dc.identifier.bibliographicCitation | 16th Annual Congress of European Society of Gene and Cell Therapy | - |
dc.relation.isPartOf | 16th Annual Congress of European Society of Gene and Cell Therapy | - |
dc.citation.title | 16th Annual Congress of European Society of Gene and Cell Therapy | - |
dc.citation.conferencePlace | 벨기에 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.